Abstract
Background
Inguinal node dissection is associated with high incidence of post-operative morbidity.
Methods
We conducted a retrospective review of all patients who underwent inguinal node dissection at The Christie Hospital between 2001 and 2008. Two hundred thirty two patients undergoing 247 inguinal node dissection outcomes were assessed with a median follow-up of 29 months (range 5 to 75).
Results
Our overall complication rate was 61 %. Our wound infection rate is 34 % with 10 % wound necrosis, 25 % wound breakdown, 35 % seroma, 23 % lymphoedema and 0.4 % haematoma rate. The overall and individual complication rate, including infection wound breakdown, skin necrosis, seroma formation and lymphoedema, was significantly lower with use of a transverse incision for access compared to using a Lazy S and longitudinal incisions (P < 0.008 and P < 0.0001, respectively). Patients undergoing Sartorius switch had a reduced rate of seroma formation (P = 0.018). The preservation of the long saphenous veins was also associated with a reduction on the overall complication rate (P = 0.007).
Conclusions
Inguinal node dissection postoperative complications are reduced by transverse incision, Sartorius switch and preservation of the long saphenous vein.
Level of Evidence: Level IV, prognostic/risk study.
Similar content being viewed by others
References
Rouzier R, Haddad B, Dubenard G, Dubois P, Paniel BJ (2003) Inguinofemoral dissection for carcinoma of the vulva: effect of modifications of extent and technique on morbidity and survival. J Am Coll Surg 1996(3):442–450
Paley J, Johnson PR, Adcock LL et al (1997) The effect of Sartorius transposition on wound morbidity following inguinal–femoral lymphadenectomy. Gynecol Oncol 64:237–241
Spiess PE, Hermandez MS, Pettaway CA (2009) Contemporary lymph node dissection: minimizing complications. World J Urol 27(2):205–212
Poos HP, Kruijff S, Bastiaannet E, van Ginkel RJ, Hoekstra HJ (2007) Therapeutic groin dissection for melanoma: risk factors for short term morbidity. Eur J Surg Oncol 33(1):102–108
Beitsch P, Balch C (1992) Operative morbidity and risk factor assessment in melanoma patients undergoing inguinal lymph node dissection. Am J Surg 164:462–465
Dardarian TS, Gray HJ, Morgan MA, Rubin SC, Randall TC (2006) Saphenous vein sparing during inguinal lymphadenectomy to reduce morbidity in patients with vulvar carcinoma. Gynecol Oncol 101:140–142
Lawton G, Rasque H, Ariyan S (2002) Preservation of muscle fascia to decrease lymphedema after complete axillary and ilioinguinofemoral lymphadenectomy for melanoma. J Am Coll Surg 195:339–351
Erba P, Wettstein R, Rieger UM, Haug M, Pierer G, Kalbermatten DF (2008) A study of the effect of Sartorius transposition on lymph flow after ilioinguinal node dissection. Ann Plast Surg 61(3):310–313
Tonouchi H, Ohmori Y, Kobayashi M et al (2004) Operative morbidity associated with groin dissections. Surg Today 34(5):413–418
Urist MM, Maddox WA, Kennedy JE, Balch CM (1983) Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients. Cancer 51:2152–2156
Serpell JW, Carne PWG, Bailey M (2003) Radical lymph node dissection for melanoma. ANZ J Surg 73:294–299
Karakousis CP (1998) Therapeutic node dissections in malignant melanoma. Ann Surg Oncol 5:473–482
Shaw JH, Rumball EM (1990) Complications and local recurrence following lymphadenectomy. Br J Surg 77:760–764
De Vries M, Vonkeman WG, Van Ginkel RJ, Hoekstra HJ (2006) Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma. Eur J Surg Oncol 32:785–789
Baas PC, Schraffordt Koops H, Hoekstra HJ, Oosterhuis JW, Oldhoff J (1992) Groin dissection in the treatment of lower-extremity melanoma. Short-term and long-term morbidity. Arch Surg 127:281–286
Karakousis CP, Driscoll DL (1994) Groin dissection in malignant melanoma. Br J Surg 81:1771–1774
Hughes TMD, Thomas JM (1999) Combined inguinal and pelvic lymph node dissection for stage II melanoma. Br J Surg 86:1493–1498
Van Akkooi ACJ, Bouwhuis MG, Van Geel AN et al (2007) Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma. Eur J Surg Oncol 33:102–108
Hughes TMD, A’Hern RP, Thomas JM (2000) Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg 87:892–901
Judson PL, Jonson AL, Paley PJ et al (2004) A prospective, randomized study analyzing Sartorius transposition following inguinal–femoral lymphadenectomy. Gynecol Oncol 95(1):226–230
Karakousis CP, Driscoll DL, Rose B, Walsh DL (1994) Groin dissection in malignant melanoma. Ann Surg Oncol 1(4):271–27
Johnson DE, Lo RK (1984) Complications of groin dissection in penile cancer: experience with 101 lymphadenectomies. Urology 24(4):312–314
Kamat MR, Kulkarni JN, Tongaonkar HB (1993) Carcinoma of the penis: the Indian experience. J Surg Oncol 52:50–55
Lopes A, Hidalgo GS, Kowalski LP, Torlani H, Rossi BM, Fonseca FP (1996) Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J Urol 156:1637–1642
Ravi R (1993) Morbidity following groin dissection for penile carcinoma. Br J Urol 72:941–945
Darai E, Karaitianos I, Durand JC (1988) Treatment of inguinal lymph nodes in cancer of the penis: apropos of 85 cases treated at the Institut Curie. Ann Chir 42:748–752
Ayyappan K, Ananthakrishnan N, Sankaran V (1994) Can regional lymph node involvement be predicted in patients with carcinoma of the penis? Br J Urol 73:549–553
Bevan-Thomas R, Slaton JW, Pettaway CA (2002) Contemporary morbidity from lymphadenectomy for penile squamous cell carcinoma: the M. D. Anderson Cancer Centre experience. J Urol 167:1638–1642
Nelson BA, Cookson MS, Smith JAJ, Chang SS (2004) Complications of inguinal and pelvic lymphadenectomy for squamous cell carcinoma of the penis: a contemporary series. J Urol 172:494–497
Swan MC, Furniss D, Cassel OCS (2004) Surgical management of metastatic inguinal lymphadenopathy. BMJ 329(7477):1272–1276
Mortenson MM, Xing Y, Weaver S et al (2008) Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma: a randomized controlled trial (CNT 00506311). World J Surg Oncol 6:63
Acknowledgement
We would like to thank The Department of Medical Records at The Christie Hospital for their assistance with this project.
Conflict of Interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rimouche, S., Ball, S., Kumar, P. et al. Key factors in reducing morbidity following inguinal node dissections. Eur J Plast Surg 36, 171–178 (2013). https://doi.org/10.1007/s00238-012-0757-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00238-012-0757-4